BeneVir Biopharm, Inc. — Form D/A
BeneVir Biopharm, Inc. of Gaithersburg, MD, a company, filed a Form D amendment with the SEC on 2016-08-31. The offering totals $12.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-08-31
- Form: D/A
- Accession: 0001626108-16-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $6.0M
- Remaining: $6.0M
- Minimum investment: $2.0M
- Investors: 1
- Date of first sale: 2014-11-12
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-228907
Issuer
- Name: BeneVir Biopharm, Inc.
- CIK: 0001626108
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 708 Quince Orchard Road, Gaithersburg, MD, 20878
- Phone: 240-474-5280
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| David Charles Kirn | Director | Gaithersburg, MD |
| Cherine Charles Plumaker | Director | Gaithersburg, MD |
| Katherine Ann Sacksteder | Director | Gaithersburg, MD |
| Katherine Ann Sacksteder | Executive Officer | Gaithersburg, MD |
| David Charles Present | Director | Gaithersburg, MD |
| Matthew Charles Mulvey | Director | Gaithersburg, MD |
| Matthew Charles Mulvey | Executive Officer | Gaithersburg, MD |
Other filings by this issuer (3)
More